Metastatic colorectal carcinoma (MCRC)
Clinical trials for Metastatic colorectal carcinoma (MCRC) explained in plain language.
Never miss a new study
Get alerted when new Metastatic colorectal carcinoma (MCRC) trials appear
Sign up with your email to follow new studies for Metastatic colorectal carcinoma (MCRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cutting scans, keeping safety: a new streamlined approach to liver cancer treatment
Disease control Recruiting nowThis trial tests a streamlined version of radioembolization, a treatment that delivers tiny radioactive beads directly to liver tumors. The standard procedure requires extra imaging beforehand to check for radiation leakage to the lungs, which can delay treatment. For patients wi…
Matched conditions: METASTATIC COLORECTAL CARCINOMA (MCRC)
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New drug targets Hard-to-Treat colorectal cancer in early trial
Disease control Recruiting nowThis study tests a new drug, tegavivint, in people with metastatic colorectal cancer that has worsened after at least two prior treatments. The trial aims to find a safe dose and see if the drug shrinks tumors when used alone or with standard therapies. About 126 adults with spec…
Matched conditions: METASTATIC COLORECTAL CARCINOMA (MCRC)
Phase 1/2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Blood test could reveal hidden cancer spread in colorectal patients
Diagnosis Recruiting nowThe EXELION study is testing a new blood test that looks for tiny particles called exosomal microRNAs to find out if colorectal cancer has spread beyond the liver. Current scans often miss small or hidden metastases, which can affect treatment options. The study will enroll 500 a…
Matched conditions: METASTATIC COLORECTAL CARCINOMA (MCRC)
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Can a common drug help cancer patients regain appetite?
Symptom relief Recruiting nowThis study tests whether olanzapine, a drug already used for other conditions, can help cancer patients who are losing weight and appetite. About 66 adults with advanced lung, stomach, or bowel cancers will receive either olanzapine or a placebo. The goal is to see if olanzapine …
Matched conditions: METASTATIC COLORECTAL CARCINOMA (MCRC)
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC